PMC:7205724 / 20816-21034 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"718","span":{"begin":123,"end":124},"obj":"Gene"},{"id":"721","span":{"begin":5,"end":8},"obj":"Species"},{"id":"722","span":{"begin":116,"end":122},"obj":"Species"}],"attributes":[{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"Gene:43740568"},{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"Tax:10116"},{"id":"A722","pred":"tao:has_database_id","subj":"722","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T153","span":{"begin":16,"end":30},"obj":"Body_part"},{"id":"T154","span":{"begin":155,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A153","pred":"fma_id","subj":"T153","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A154","pred":"fma_id","subj":"T154","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T153","span":{"begin":105,"end":109},"obj":"Disease"},{"id":"T154","span":{"begin":116,"end":120},"obj":"Disease"}],"attributes":[{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T244","span":{"begin":179,"end":180},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T245","span":{"begin":200,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-MedDRA

    {"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T20","span":{"begin":16,"end":30},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A20","pred":"meddra_id","subj":"T20","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T200","span":{"begin":5,"end":8},"obj":"Species"},{"id":"T202","span":{"begin":105,"end":109},"obj":"Species"},{"id":"T203","span":{"begin":116,"end":122},"obj":"Species"}],"attributes":[{"id":"A200","pred":"ncbi_taxonomy_id","subj":"T200","obj":"NCBItxid:10116"},{"id":"A201","pred":"ncbi_taxonomy_id","subj":"T200","obj":"NCBItxid:10114"},{"id":"A202","pred":"ncbi_taxonomy_id","subj":"T202","obj":"NCBItxid:694009"},{"id":"A203","pred":"ncbi_taxonomy_id","subj":"T203","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"721","span":{"begin":5,"end":8},"obj":"Species"},{"id":"722","span":{"begin":116,"end":122},"obj":"Species"},{"id":"718","span":{"begin":123,"end":124},"obj":"Gene"}],"attributes":[{"id":"A721","pred":"pubann:denotes","subj":"721","obj":"Tax:10116"},{"id":"A722","pred":"pubann:denotes","subj":"722","obj":"Tax:2697049"},{"id":"A718","pred":"pubann:denotes","subj":"718","obj":"Gene:43740568"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T78221","span":{"begin":1,"end":4},"obj":"CC"},{"id":"T28318","span":{"begin":5,"end":8},"obj":"NN"},{"id":"T19776","span":{"begin":9,"end":15},"obj":"NN"},{"id":"T32531","span":{"begin":16,"end":30},"obj":"NN"},{"id":"T16968","span":{"begin":31,"end":39},"obj":"NN"},{"id":"T56920","span":{"begin":40,"end":47},"obj":"NNS"},{"id":"T36716","span":{"begin":48,"end":52},"obj":"VBD"},{"id":"T74827","span":{"begin":53,"end":57},"obj":"VBN"},{"id":"T21382","span":{"begin":58,"end":60},"obj":"TO"},{"id":"T11788","span":{"begin":61,"end":67},"obj":"VB"},{"id":"T40665","span":{"begin":68,"end":78},"obj":"NNS"},{"id":"T56747","span":{"begin":79,"end":83},"obj":"WDT"},{"id":"T54239","span":{"begin":84,"end":87},"obj":"MD"},{"id":"T71867","span":{"begin":88,"end":93},"obj":"VB"},{"id":"T35671","span":{"begin":94,"end":104},"obj":"VB"},{"id":"T77445","span":{"begin":105,"end":111},"obj":"NN"},{"id":"T34654","span":{"begin":112,"end":115},"obj":"CC"},{"id":"T83470","span":{"begin":116,"end":124},"obj":"NN"},{"id":"T76245","span":{"begin":125,"end":126},"obj":"-LRB-"},{"id":"T33581","span":{"begin":126,"end":128},"obj":"CD"},{"id":"T80577","span":{"begin":128,"end":129},"obj":"-RRB-"},{"id":"T78516","span":{"begin":131,"end":134},"obj":"CD"},{"id":"T34464","span":{"begin":135,"end":143},"obj":"JJ"},{"id":"T13041","span":{"begin":144,"end":149},"obj":"NN"},{"id":"T83927","span":{"begin":150,"end":154},"obj":"NN"},{"id":"T57345","span":{"begin":155,"end":163},"obj":"NN"},{"id":"T44833","span":{"begin":164,"end":173},"obj":"VBD"},{"id":"T94688","span":{"begin":174,"end":178},"obj":"PDT"},{"id":"T52983","span":{"begin":179,"end":180},"obj":"DT"},{"id":"T30646","span":{"begin":181,"end":199},"obj":"JJ"},{"id":"T37245","span":{"begin":200,"end":208},"obj":"NN"},{"id":"T11300","span":{"begin":208,"end":209},"obj":"-COMMA-"}],"relations":[{"id":"R33937","pred":"arg2Of","subj":"T56920","obj":"T78221"},{"id":"R92294","pred":"arg1Of","subj":"T56920","obj":"T28318"},{"id":"R87268","pred":"arg1Of","subj":"T56920","obj":"T19776"},{"id":"R7737","pred":"arg1Of","subj":"T56920","obj":"T32531"},{"id":"R98342","pred":"arg1Of","subj":"T56920","obj":"T16968"},{"id":"R67139","pred":"arg2Of","subj":"T74827","obj":"T36716"},{"id":"R69341","pred":"arg3Of","subj":"T11788","obj":"T74827"},{"id":"R12801","pred":"arg1Of","subj":"T11788","obj":"T21382"},{"id":"R52958","pred":"arg2Of","subj":"T40665","obj":"T11788"},{"id":"R77806","pred":"arg1Of","subj":"T40665","obj":"T56747"},{"id":"R37476","pred":"arg1Of","subj":"T40665","obj":"T54239"},{"id":"R87983","pred":"arg2Of","subj":"T35671","obj":"T54239"},{"id":"R24714","pred":"arg1Of","subj":"T40665","obj":"T71867"},{"id":"R29418","pred":"arg2Of","subj":"T35671","obj":"T71867"},{"id":"R8917","pred":"arg1Of","subj":"T40665","obj":"T35671"},{"id":"R70086","pred":"arg2Of","subj":"T34654","obj":"T35671"},{"id":"R88560","pred":"arg1Of","subj":"T77445","obj":"T34654"},{"id":"R74668","pred":"arg2Of","subj":"T83470","obj":"T34654"},{"id":"R89642","pred":"arg1Of","subj":"T35671","obj":"T76245"},{"id":"R10178","pred":"arg2Of","subj":"T33581","obj":"T76245"},{"id":"R12224","pred":"arg3Of","subj":"T80577","obj":"T76245"},{"id":"R55425","pred":"arg1Of","subj":"T57345","obj":"T78516"},{"id":"R85824","pred":"arg1Of","subj":"T57345","obj":"T34464"},{"id":"R91166","pred":"arg1Of","subj":"T57345","obj":"T13041"},{"id":"R74139","pred":"arg1Of","subj":"T57345","obj":"T83927"},{"id":"R37082","pred":"arg1Of","subj":"T57345","obj":"T44833"},{"id":"R42165","pred":"arg2Of","subj":"T37245","obj":"T44833"},{"id":"R8404","pred":"arg1Of","subj":"T37245","obj":"T94688"},{"id":"R58851","pred":"arg1Of","subj":"T37245","obj":"T52983"},{"id":"R6725","pred":"arg1Of","subj":"T37245","obj":"T30646"},{"id":"R48595","pred":"arg1Of","subj":"T44833","obj":"T11300"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T153","span":{"begin":16,"end":30},"obj":"Body_part"},{"id":"T154","span":{"begin":155,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A153","pred":"fma_id","subj":"T153","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A154","pred":"fma_id","subj":"T154","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T148","span":{"begin":105,"end":109},"obj":"Disease"},{"id":"T149","span":{"begin":116,"end":120},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" and rat origin immunoglobulin constant regions were used to detect antibodies that can cross neutralize SARS-S and SARS-2-S [26]. One chimeric 47D11 H2L2 antibody displayed such a cross-neutralizing activity, decrease"}